A rapid test for the qualitative detection of circulating antigens of Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale, Plasmodium malariae in whole blood. For professional in vitro diagnostic use only. Sensitivity The Malaria P.f/ Pan Rapid Test Device (Whole Blood) has been tested with thin or thick microscopy on clinical samples. The results show that the sensitivity of the Malaria P.f/ Pan Rapid Test Device (Whole Blood) is >99.9% relative to microscopy. For Pan: Relative Sensitivity: >99.9% (158/158) (97.6%100.0%)* For P.f: Relative Sensitivity: >99.9% (53/53) (93%100.0%)* Specificity The Malaria P.f/ Pan Rapid Test Device (Whole Blood) uses highly specific antibodies for Malaria P.f/ Pan antigens in whole blood. The results show that the specificity of the Malaria P.f/ Pan. Rapid Test Device (Whole Blood) is over 99.0% relative to microscopy. Relative Specificity: >99.0% (324/327)(97.3%99.8%)* Accuracy: >99.4%(535/538)(98.3%99.8%)* * 95% Confidence Interval Total Results211327538 Note: The comparison for Pan line has been only done with blood specimens positive with Plasmodium vivax specimen. The claims for Pan lines are based on scientific findings that Pan-malarial Aldolase is found in other malarial parasites including Plasmodium ovale and Plasmodium malariae.
Troponin I (CTnI) One Step Rapid Test Kit (Whole blood/serum/plasma) Product description Product name: CTnI One Step Troponin I Rapid Test Kit Specification: Lateral-flow Immunofluorescence Chromatographic Assay 10 pcs, 25 pcs, 50 pcs, 100 pcs/box, or customized Type: Cassette MOQ: 10,000 PCS Analytical Range: 1.0~50ng/ml (Whole Blood); 0.1~50ng/ml (Serum/Plasma) Specimen: Human serum/plasma/whole blood Manufacturer: Hangzhou Laihe Biotech Co., Ltd. 2.Clinical significance (1)Diagnosis of various chest pain (2)Foundation of ACS diagnosis and risk stratification (3)Best markers for ACS prognosis (4)An aid in the diagnosis of myocardial infarction (injury) (5)Can improve clinical, economic and operational outcomes
In One Cup Cup Multi-drug One Step 2-15 Drug Test Simple Cup (Urine) CE Qualified (MOP/MET/KET/AMP/BAR/BUP/BZO/COC/COT/MDMA/THC/MTD/OPI/PCP/TCA)
Hello,Sir Or Madam! Good News For You! I'm Tony Tsui, The Executive Of Runway Group. We Runway Group have successfully R&D the New Very Hot Hot Hot Product :COVID-19 Antibody Rapid Test kits .This Has been used and inspected by many hospitals In Wuhan And China Other Cities ,Now,our test kit FDA&CE Approved Certificates,it can sell all the world. It Is very hot product For many countries ,many governments ,many Hospitals for all the World! Now We Wanted The Exclusive Agent In Your Country in all the world! CIFCustomer Country Unit Price :xx Usd/pcs ,MOQ:0.2million Pcs ,3-5 working days shipment. When We Received 100% Prepayment By T/T or L/C AT SIGHT.
Intended use: Toxoplasma IGG/IGM rapid test is a rapid immunochromatographic test for the simultaneous detection of IGM and IGG antibodies to toxoplasma gondii in human serum/plasma. The test can be used as a screening test for toxoplasma infection and as an aid for differential diagnosis of the self limiting primary toxoplasma infections and the potentially fatal secondary toxoplasma infections in conjunction with other criteria. Test principle: The toxoplasma IGG/IGM rapid test is a lateral flow chromatographic immunoassay. The test cassette consists of: 1) A burgundy colored conjugate pad containing toxoplasma recombinant envelope antigens conjugated with colloid gold (toxoplasma conjugates) and rabbit igg-gold conjugates, 2) A nitrocellulose membrane strip containing two test bands (t1 and t2 bands) and a control band (c band). The t1 band is pre-coated with the antibody for the detection of IGM anti-toxoplasma, t2 band is coated with antibody for the detection of igg anti-toxoplasma, and the c band is pre-coated with goat anti rabbit IGG. Absence of any t bands (t1 and t2) suggests a negative result. The test contains an internal control (c band) which should exhibit a burgundy colored band of the immunocomplex of goat anti rabbit igg/rabbit igg-gold conjugate regardless of the color development on any of the t bands. Otherwise, the test result is invalid and the specimen must be retested with another device. Reagents and materials supplied : 1. Test cassette individually foil pouched with a desiccant. 2. Plastic dropper 3. Buffer 4. Package insert. Storage and stability: The kit must be stored at 2-30pc. Warning and precautions: 1. For in vitro diagnostic use only. Not for medicinal use. 2. Do not use beyond expiry date. 3. Read the instructions careful y before performing the test. 4. Handle all specimen as potential y infectious. 5. Follow standard biosafety guidelines for handling and disposal of potential y infective material.
SARS-CoV-19 IgG/IgM test kit (15min showing result) Manufacturer: Guangzhou Wanfo Biotech Co., Ltd. a China listing company Certificates: CE certificate, China NMPA approval (export allowed), no FDA approval The price is $5.5/test (FOB) Max delivered quantity: 100,000/weekly More details please enquire Barry Liu whatsapp: +8617810331113 sample available: 20 test & DHL delivery: $200 Download introductions: https://kdocs.cn/l/sLLC9O6rc
H-fabp fast test kit (immunofluorescence assay) is intended for use together with getein1100 immunofluorescence quantitative analyzer (getein1100) or getein1600 immunofluorescence quantitative analyzer (getein1600) to quantitatively determine the concentrations of h-fabp in human serum, plasma, or whole blood specimens in point-of care and laboratory settings. H-fabp fast test kit (immunofluorescence assay) is intended for in vitro quantitative determination of heart-type fatty acid binding protein (h-fabp) in serum, plasma or whole blood. This test is used in the early diagnosis of ami and pulmonary embolism, and monitoring of chronic heart failure.
1pc/box; 5pc/box; 25pc/box;
Guarddent supplies sponge gauze dressings can be medicated or impregnated with antiseptic or made for wound debridement -- specifically in cases where the wound is large and the incidence of necrotic tissue may be present.
